Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00010699 · ClinicalTrials.gov registry record · Phase 2
Effect of High Dose Vitamin E on Carotid Atherosclerosis
A Phase 2 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 2
- Development phase
- 120
- Enrollment target
NCT00010699 is a Phase 2 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 120 participants.
The verdict
NCT00010699, a Phase 2 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 120 participants
- Enrollment target
Study Summary
The primary aim of the present study is to test the effect of alpha-tocopherol supplementation on the progression of carotid atherosclerosis in patients with coronary artery disease
Interventions
- DRUG Vitamin E
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Est. Completion | 2003-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00010699
The ClinicalTrials.gov registry entry for NCT00010699 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vitamin E is the first listed.
NCT00010699 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00010699 about?
NCT00010699 is a clinical study titled "Effect of High Dose Vitamin E on Carotid Atherosclerosis". The primary aim of the present study is to test the effect of alpha-tocopherol supplementation on the progression of carotid atherosclerosis in patients with coronary artery disease
What is the current status of trial NCT00010699?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 120 participants. Estimated completion is 2003-04.
What interventions are being tested in trial NCT00010699?
The interventions under investigation include: Vitamin E (DRUG).
Who is sponsoring clinical trial NCT00010699?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.